Blood Tests for Alzheimer Disease
Henrik Zetterberg, MD, PhD; Deborah O.T. Alawode, BSc; Ashvini Keshavan, MRCP, PhD; Antoinette O’Connor, MRCPI; Philip S. J. Weston, MRCP, PhD; Ross W. Paterson, MRCP, PhD; Amanda Heslegrave, PhD; Nick C. Fox, MD, FRCP, FMedSci; Michael P. Lunn, FRCP, PhD; and Jonathan M. Schott, MD, FRCP
Blood tests for Alzheimer disease are moving toward clinical implementation and interpretation.
12.01.20Vatiquinone Phase 3 Trial Initiated for Potential Treatment of Friedreich Ataxia
11.20.20Real-World Use of Wrist-worn Neuromodulation Treatment of Essential Tremors
11.19.20Stem Cell Treatment Responses Fails to Reach Statistical Significance and Has High Placebo Response Rate
Physical and Cognitive Activity for Dementia
There is enough evidence of the neuroprotective effects of physical and cognitive activity to recommend these to patients.
Ajay Sood, MD, PhD, and David Bennett, MD
Guest Medical Editor's Page
After years in development, many innovations are poised to move into clinical practice.
Nupur Ghoshal, MD, PhD
11.16.20Higher Incidence of Restless Legs Syndrome in Pregnancy Is Not Accounted for by Ethnicity
11.09.20FDA Clears IND Application of Gene Therapy for Tay-Sachs and Sandhoff Diseases
11.09.20Neflamapimod Improves Cognition in Dementia With Lewy Bodies in Phase 2 Trial
10.30.20First Participant Treated in Phase 3 Trial of Tavapadon for Motor Symptoms of Parkinson Disease
10.23.20FDA Grants Breakthrough Device Status to External Neuromodulator for Essential Tremor
Movement Disorders Moment: Treatment Approaches to Cervical Dystonia
Botulinum toxins are effective treatment.
Zehra Farzal, MD; Guillaume Lamotte MD, MSc; Elizabeth Mundel, MD; Laxman B. Bahroo, DO; and Fernando L. Pagan, MD
10.16.20DaxibotulinumtoxinA Provides Clinically Meaningful Improvement of Cervical Dystonia in Phase 3 Trial
10.06.20Gene Therapy Improves ON Time for Individuals With Parkinson Disease in Phase 3 Trial
09.23.20Individuals with Parkinson Disease More Likely to Have Orthostatic Hypotension
09.18.20One-Time Gene Therapy Delivered Neurosurgically Delivered to Striatum Provided Sustained Motor Function Improvements in Parkinson Disease
Trending Autoantibodies Causing Movement Disorders
As new autoantibodies are described, the field of autoimmune movement disorders is ever expanding.
F. Stephen Benesh, MD, and Shruti P. Agnihotri, MD
Immune-Mediated Cerebellar Ataxias
Cerebellar ataxia may be a prominent feature in autoimmune encephalitis and paraneoplastic syndromes.
Fabio Fieni Toso, MD; Rene de Araújo Gleizer, MD; and Lívia Almeida Dutra, MD, PhD